CAS NO: | 1123231-07-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | WAY-262611 is a winglessβ-Cateninagonist that increases bone formation rate with anEC50of 0.63 μM in TCF-Luciferase assay. WAY-262611 is also aDkk1inhibitor. | ||||||||||||||||
IC50& Target | EC50: 0.63 μM (β-Catenin)[1] | ||||||||||||||||
体外研究 (In Vitro) | WAY-262611 has the most potent activity in the primary assay, low kinase inhibition potential, and high solubility[1]. | ||||||||||||||||
体内研究 (In Vivo) | WAY-262611 has excellent pharmacokinetic properties and shows a dose dependent increase in the trabecular bone formation rate in ovariectomized rats following oral administration. Calvariae from wt mice treated with WAY-262611 shows statistically increased BFR, while similarly treated KO animals are no different from control. This indicates that WAY-262611 is acting via the Wntβ-catenin pathway and most likely through inhibition of Dkk-1[1]. | ||||||||||||||||
分子量 | 318.42 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H22N4 | ||||||||||||||||
CAS 号 | 1123231-07-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 42 mg/mL(131.90 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|